☆ 4.7 Meeting Abstract

Expanding the role of medical oncologist in the management of COVID-19

ANNALS OF ONCOLOGY (2020)

Journal

ANNALS OF ONCOLOGY

Volume 31, Issue -, Pages S1012-S1012

Publisher

ELSEVIER

DOI: 10.1016/j.annonc.2020.08.1790

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Environmental Sciences

Estimation of COVID-19 generated medical waste in the Kingdom of Bahrain

Khadija Al-Omran, Ezzat Khan, Nisar Ali, Muhammad Bilal

Summary: The COVID-19 pandemic has generated a significant amount of waste, posing a serious threat to the environment and potentially leading to secondary complications. It is important for all parties involved to pay more attention to and assess the impact of this waste on the environment and human health.

SCIENCE OF THE TOTAL ENVIRONMENT (2021)

Add to Collection

Article Immunology

Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)

Madhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, Andrew E. Clark, Kathleen Wilkinson, Sruthi Yekkaluri, Jasmin Tiro, Francesca M. Lee, Jyoti Balani, Ravi Sarode, Amit G. Singal, Alagarraju Muthukumar

Summary: The study evaluated the utility of a combination orthogonal serological testing (COST) algorithm alongside RT-PCR to quantify infection prevalence, with the aim of identifying patient clusters for single dose and/or delayed vaccination. The results showed that IgG(NC) serology could identify twice the number of COVID-positive cases compared to RT-PCR alone, and COST further increased the number of detected positive cases, demonstrating its potential as an effective tool for vaccination prioritization.

VACCINES (2021)

Add to Collection

Article Education, Scientific Disciplines

The Role of Medical Student Government in Responding to COVID-19

Sam Schuiteman, Nadine I. Ibrahim, Ali Hammoud, Laura Kruger, Rajesh S. Mangrulkar, Michelle Daniel

Summary: The COVID-19 outbreak created chaos in academic health centers, overwhelming medical students with questions and leaving them feeling confused due to inadequate responses from administrators. Leaders from the University of Michigan Medical School Student Council and medical school deans collaborated to bridge the gap and provide necessary guidance during the crisis.

ACADEMIC MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

The COVID-19 pandemic reveals the wide-ranging role of biobanks

Dovile Juozapaite, Mantas Minkauskas, Inga Laurinaityte, Martyna Simutyte, Laimonas Griskevicius, Daniel Naumovas

Summary: The COVID-19 pandemic has had an unprecedented impact in terms of its spread and mortality rate, requiring collaboration from governments, hospitals, private companies, and other organizations for mitigation. Biobanks, as intermediaries between clinical practice and research, play a significant role in this process. Their expertise in biospecimen and health information collection, sample preparation and storage, bioethics, and project management enables them to alleviate the burden of a pandemic. This paper presents the involvement of Vilnius Santaros Klinikos Biobank (BB VSK), Lithuania in the national management of the pandemic and discusses the role of biobanks in preparing for and managing future pandemics.

FRONTIERS IN PUBLIC HEALTH (2023)

Add to Collection

Article Psychology, Multidisciplinary

The Role of the Psycho-Oncologist during the COVID-19 Pandemic: A Clinical Breast Cancer Case Report

Giulia Silvestri, Caterina Borgese, Samuela Sommacal, Letizia Iannopollo, Grazia Cristaldi, Samantha Serpentini

Summary: Breast cancer patients experience increased psychological stress and distress during the COVID-19 pandemic, highlighting the importance of prioritizing psychological care in oncology.

BEHAVIORAL SCIENCES (2022)

Add to Collection

Article Communication

Medical Students' Stress and Uncertainty During the COVID-19 Pandemic

Anna M. Kerr, Lauren D. Spaeth, Jody M. Gerome

Summary: The COVID-19 pandemic has led to significant stress and uncertainty nationwide. This study examines how medical students cope with the disruption caused by COVID-19 in their training. The findings show that students commonly use coping strategies such as distraction, acceptance, planning, positive reframing, and emotional support. Coping strategies vary depending on the year in training, and personal uncertainty emerges as the most prominent form of uncertainty. Students face barriers such as constant exposure, inadequate information, rumination, and extreme responses, while facilitators include distraction, instrumental support, emotional support, network support, and positive reframing.

HEALTH COMMUNICATION (2023)

Add to Collection

Editorial Material Medicine, General & Internal

The COVID-19 Pandemic in Serial Medical Dramas

Irene Cambra-Badii, Elena Guardiola, Josep-E Banos

Summary: This feature summarizes how the coronavirus pandemic was portrayed in serial medical dramas aired between November 2020 and May 2021.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Review Biochemistry & Molecular Biology

COVID-19 enters the expanding network of apolipoprotein E4-related pathologies

Kalliopi Gkouskou, Theodora Vasilogiannakopoulou, Evangelos Andreakos, Nikolaos Davanos, Maria Gazouli, Despina Sanoudou, Aristides G. Eliopoulos

Summary: Studies have shown lower frequency of the APOE e4/e4 genotype in Greek individuals compared to the British cohort, potentially resulting in fewer severe cases of COVID-19. Researchers hypothesize that APOE e4/e4 may increase susceptibility to infection and exacerbate lung inflammation through metabolic deregulation.

REDOX BIOLOGY (2021)

Add to Collection

Review Environmental Sciences

Pyrolysis: An effective technique for degradation of COVID-19 medical wastes

Selvakumar Dharmaraj, Veeramuthu Ashokkumar, Rajesh Pandiyan, Heli Siti Halimatul Munawaroh, Kit Wayne Chew, Wei-Hsin Chen, Chawalit Ngamcharussrivichai

Summary: The rise of medical wastes due to COVID-19 poses challenges in waste management, but pyrolysis offers an environmentally friendly and cost-effective solution, converting medical waste into valuable energy products and reducing landfill capacity and pollution.

CHEMOSPHERE (2021)

Add to Collection

Review Psychology, Multidisciplinary

Academic Management in Uncertain Times: Shifting and Expanding the Focus of Cognitive Load Theory During COVID-19 Pandemic Education

Douglas J. Gould, Kara Sawarynski, Changiz Mohiyeddini

Summary: Globally, the COVID-19 pandemic has led to a shift in medical education towards online approaches, impacting medical educators and learners. To address the challenges posed by this unprecedented situation, the Cognitive Load Theory (CLT) was refocused on instructors, with principles implemented to reduce their extraneous load and support their scholarly activity and well-being.

FRONTIERS IN PSYCHOLOGY (2022)

Add to Collection

Article Engineering, Industrial

Role of additive manufacturing in medical application COVID-19 scenario: India case study

Piyush Patel, Piyush Gohil

Summary: This paper highlights the crucial role played by the Additive Manufacturing industry in combating the spread of the Coronavirus by swiftly providing customized parts locally, reducing waste, and addressing the shortage of medical components. It suggests that in the future, the technology could be expanded to centralized model storehouses with innovative open-source models to enhance emergency responses during crises.

JOURNAL OF MANUFACTURING SYSTEMS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of Endothelium in COVID-19

Mihaela Ionescu, Anca Pantea Stoian, Manfredi Rizzo, Dragos Serban, Domenico Nuzzo, Laura Mazilu, Andra Iulia Suceveanu, Ana Maria Dascalu, Irinel Raluca Parepa

Summary: The 2019 novel coronavirus, COVID-19, can lead to cardiovascular issues, particularly in patients with preexisting conditions. Endothelial dysfunction may result in impaired organ perfusion and thrombus formation, worsening the condition. Research focuses on understanding this mechanism and providing treatment options.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of Immunogenetics in COVID-19

Fanny Pojero, Giuseppina Candore, Calogero Caruso, Danilo Di Bona, David A. Groneberg, Mattia E. Ligotti, Giulia Accardi, Anna Aiello

Summary: COVID-19, induced by SARS-CoV-2, manifests a spectrum of clinical symptoms, with genetic variants in immunogenetics potentially playing a significant role in disease evolution and treatment. Researchers are investigating the impact of these variants on disease progression, aiming to improve patient outcomes through personalized therapeutic strategies and drug repurposing.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Business

Innovation in crisis: The role of 'exaptive relations' for medical device development in response to COVID-19

Steffan James, Zheng Liu, Victoria Stephens, Gareth R. T. White

Summary: The COVID-19 pandemic has caused significant disruption to the healthcare sector, leading to an acceleration of medical innovations. This study aims to understand the nature of micro-relations within medical innovations during the COVID-19 crisis and examines the performance of medical innovation in response to the crisis.

TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2022)

Add to Collection

Article Medicine, General & Internal

Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics

Alyaa Elhazmi, Ahmed A. Rabie, Awad Al-Omari, Hani N. Mufti, Hend Sallam, Mohammed S. Alshahrani, Ahmed Mady, Adnan Alghamdi, Ali Altalaq, Mohamed H. Azzam, Anees Sindi, Ayman Kharaba, Zohair A. Al-Aseri, Ghaleb A. Almekhlafi, Wail Tashkandi, Saud A. Alajmi, Fahad Faqihi, Abdulrahman Alharthy, Jaffar A. Al-Tawfiq, Rami Ghazi Melibari, Yaseen M. Arabi

Summary: This study found that tocilizumab treatment improved the 28 day hospital survival of critically ill COVID-19 patients admitted to the ICU, and the concurrent use of other COVID-19 medical therapeutics did not affect this outcome.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Oncology

Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study

A. Bayle, L. Belcaid, M. Aldea, D. Vasseur, F. Peyraud, C. Nicotra, A. Geraud, M. Sakkal, L. Seknazi, L. Cerbone, F. Blanc-Durand, J. Hadoux, F. Mosele, M. Tagliamento, A. Bernard-Tessier, B. Verret, C. Smolenschi, R. Clodion, N. Auger, P. M. Romano, A. Gazzah, M. N. Camus, J. Micol, O. Caron, A. Hollebecque, Y. Loriot, B. Besse, L. Lacroix, E. Rouleau, S. Ponce, J. C. Soria, F. Barlesi, F. Andre, A. Italiano

Summary: This study demonstrates that comprehensive molecular profiling of ctDNA is a promising approach for tailoring therapy in patients with advanced solid tumors, resulting in positive clinical outcomes.

ANNALS OF ONCOLOGY (2023)

Add to Collection

Review Oncology

Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer

Claudette Falato, Francesco Schettini, Tomas Pascual, Fara Braso-Maristany, Aleix Prat

Summary: Traditionally, breast cancer classification has relied on the expression of immunohistochemical bio-markers available in clinical practice. However, intrinsic molecular subtypes based on gene expression have been identified and show different characteristics compared to IHC-based subgroups. Hormone receptor-positive tumors can demonstrate non-luminal biology, which has prognostic value and impacts sensitivity to treatment. Genomic instability, cell plasticity, treatment selective pressure, and tumor microenvironment all contribute to the diversity observed between primary and metastatic breast cancer. This review focuses on hormone receptor-positive/HER2-negative advanced breast cancer and discusses the distribution and clinical behavior of intrinsic subtypes, as well as ongoing clinical trials investigating their predictive and prognostic value for routine care.

CANCER TREATMENT REVIEWS (2023)

Add to Collection

Article Oncology

Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non- small cell lung cancer

Adrien Rousseau, Marco Tagliamento, Edouard Auclin, Mihaela Aldea, Maxime Frelaut, Antonin Levy, Jose C. Benitez, Charles Naltet, Pernelle Lavaud, Angela Botticella, Miruna Grecea, Nathalie Chaput, Fabrice Barlesi, David Planchard, Benjamin Besse

Summary: This study aimed to investigate the impact of the time-of-day infusion of immune checkpoint inhibitors (ICI) on the survival of patients with advanced non-small cell lung cancer (NSCLC). The results showed that patients who received at least 20% of ICI infusions after 16:30h had a significantly shorter overall survival and slightly shorter progression-free survival. However, the total number of ICI infusions and underlying prognostic characteristics may confound the results.

EUROPEAN JOURNAL OF CANCER (2023)

Add to Collection

Article Oncology

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer

Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, Ramon Salazar, Nadia Harbeck, Lucia Del Mastro, Juan Aguilar-Company, Mark Bower, Rachel Sharkey, Alessia Dalla Pria, Andrea Plaja, Amanda Jackson, Jasmine Handford, Ailsa Sita-Lumsden, Clara Martinez-Vila, Marta Matas, Ana Miguel Rodriguez, Bruno Vincenzi, Giuseppe Tonini, Alexia Bertuzzi, Joan Brunet, Paolo Pedrazzoli, Francesca D'Avanzo, Federica Biello, Alasdair Sinclair, Alvin J. X. Lee, Sabrina Rossi, Gianpiero Rizzo, Oriol Mirallas, Isabel Pimentel, Maria Iglesias, Ana Sanchez de Torre, Annalisa Guida, Rossana Berardi, Alberto Zambelli, Carlo Tondini, Marco Filetti, Francesca Mazzoni, Uma Mukherjee, Nikolaos Diamantis, Alessandro Parisi, Avinash Aujayeb, Aleix Prat, Michela Libertini, Salvatore Grisanti, Maura Rossi, Federica Zoratto, Daniele Generali, Cristina Saura, Gary H. Lyman, Nicole M. Kuderer, David J. Pinato, Alessio Cortellini

Summary: Although breast cancer patients have lower mortality rates from COVID-19, it is important to evaluate the impact of the pandemic in different phases and the effectiveness of vaccination to inform clinical practice.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1

Fara Braso-Maristany, Gaia Griguolo, Nuria Chic, Tomas Pascual, Laia Pare, Julia Maues, Patricia Galvan, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martinez-Saez, Mercedes Marin-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Munoz, Esther Sanfeliu, Blanca Gonzalez, Ana Vivancos, Patricia Villagrasa, Joel S. Parker, Charles M. Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri

Summary: This study evaluated the association between ERBB2 mRNA expression levels and response and survival following T-DM1 treatment. The results showed that ERBB2 mRNA expression levels were associated with better survival and treatment response.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Add to Collection

Article Oncology

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Mihaela Aldea, Arianna Marinello, Michael Duruisseaux, Wael Zrafi, Nicole Conci, Giacomo Massa, Giulio Metro, Isabelle Monnet, Patricia Gomez Iranzo, Fabrizio Tabbo, Emilio Bria, Florian Guisier, Damien Vasseur, Colin R. Lindsay, Santiago Ponce-Aix, Sophie Cousin, Fabrizio Citarella, Vincent Fallet, Jose Nicolas Minatta, Anna Eisert, Hortense de Saint Basile, Clarisse Audigier-Valette, Laura Mezquita, Antonio Calles, Giannis Mountzios, Marco Tagliamento, Jordi Remon Masip, Judith Raimbourg, Safae Terrisse, Alessandro Russo, Diego Cortinovis, Philippe Rochigneux, David James Pinato, Alessio Cortellini, Camille Leonce, Anas Gazzah, Maria-Rosa Ghigna, Roberto Ferrara, Filippo Gustavo Dall'Olio, Francesco Passiglia, Vienna Ludovini, Fabrice Barlesi, Enriqueta Felip, David Planchard, Benjamin Besse

Summary: This retrospective study analyzed 218 cases of non-small cell lung cancer (NSCLC) with RET fusion mutations and found that RET inhibitors can significantly improve patient survival, while immune checkpoint inhibitors may also be effective in some patients.

JOURNAL OF THORACIC ONCOLOGY (2023)

Add to Collection

Article Oncology

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

Edouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, Francesca Parisi, Teresa Gorria, Rosario Garcia-Campelo, Naomi Dempsey, David J. Pinato, Roxana Reyes, Victor Albarran-Artahona, Filippo Dall'Olio, Davide Soldato, Lizza Hendriks, Frank Aboubakar Nana, Marion Tonneau, Rafael Lopez-Castro, Ernest Nadal, Suzanne Kazandjian, Thierry Muanza, Felix Blanc-Durand, Elizabeth Fabre, Natalia Castro, Hugo Arasanz, Adrien Rochand, Benjamin Besse, Bertrand Routy, Laura Mezquita

Summary: This study evaluated the efficacy of second-line chemotherapy treatments in patients with metastatic NSCLC after progression following first-line chemo-immunotherapy. Results showed that 52% of patients were resistant to first-line chemo-immunotherapy, and among second-line treatments, 46% received taxane monotherapy.

LUNG CANCER (2023)

Add to Collection

Letter Oncology

Reply to Bertucci, De Nonneville, and Finetti

Fara Braso-Maristany, Aleix Prat

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Add to Collection

Article Oncology

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

Alessio Cortellini, Josep Tabernero, Uma Mukherjee, Ramon Salazar, Anna Sureda, Clara Maluquer, Daniela Ferrante, Mark Bower, Rachel Sharkey, Oriol Mirallas, Andrea Plaja, Marc Cucurull, Ricard Mesia, Alessia Dalla Pria, Thomas Newsom-Davis, Mieke Van Hemelrijck, Ailsa Sita-Lumsden, Eleanor Apthorp, Bruno Vincenzi, Giuseppina Rita Di Fazio, Giuseppe Tonini, Francesco Pantano, Alexia Bertuzzi, Sabrina Rossi, Joan Brunet, Matteo Lambertini, Paolo Pedrazzoli, Federica Biello, Francesca D'Avanzo, Alvin J. X. Lee, Marianne Shawe-Taylor, Lucy Rogers, Cian Murphy, Lee Cooper, Ramis Andaleeb, Saira Khalique, Samira Bawany, Sarah Ahmed, M. Carmen Carmona-Garcia, Roser Fort-Culillas, Raquel Linan, Federica Zoratto, Gianpiero Rizzo, Marta Perachino, Kris Doonga, Gianluca Gaidano, Riccardo Bruna, Andrea Patriarca, Clara Martinez-Vila, Ignacio Perez Criado, Raffaele Giusti, Francesca Mazzoni, Lorenzo Antonuzzo, Armando Santoro, Alessandro Parisi, Paola Queirolo, Avinash Aujayeb, Lorenza Rimassa, Nikolaos Diamantis, Rossella Bertulli, Claudia A. M. Fulgenzi, Antonio D'Alessio, Isabel Ruiz-Camps, Nadia Saoudi-Gonzalez, David Garcia Illescas, Irene Medina, Laura Fox, Alessandra Gennari, Juan Aguilar-Company, David J. Pinato

Summary: This study aimed to investigate the long-term effects of previous immunization on evolving variants of SARS-CoV-2. The study found that patients who received the vaccine had fewer sequelae after COVID-19, as well as a lower incidence of respiratory complications and prolonged fatigue. This finding is important for the treatment and survival of cancer patients.

LANCET ONCOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer

Aleix Prat, Fara Braso-Maristany, Olga Martinez-Saez, Esther Sanfeliu, Youli Xia, Meritxell Bellet, Patricia Galvan, Debora Martinez, Tomas Pascual, Mercedes Marin-Aguilera, Anna Rodriguez, Nuria Chic, Barbara Adamo, Laia Pare, Maria Vidal, Mireia Margeli, Ester Ballana, Marina Gomez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sanchez-Bayona, Anna Sunol, Cristina Saura, Eva Ciruelos, Pablo Tolosa, Montserrat Munoz, Blanca Gonzalez-Farre, Patricia Villagrasa, Joel S. Parker, Charles M. Perou, Ana Vivancos

Summary: This study uses shallow WGS to create machine learning signatures to identify tumor phenotypes and predict therapy response in metastatic breast cancer patients. Machine learning multi-gene signatures obtained from ctDNA can identify complex biological features similar to those obtained from direct tumor tissue DNA or RNA profiling.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Oncology

Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab

Coralia Bueno-Muino, Isabel Echavarria, Sara Lopez-Tarruella, Marta Roche-Molina, Maria del Monte-Millan, Tatiana Massarrah, Yolanda Jerez, Francisco Ayala de la Pena, Jose angel Garcia-Saenz, Fernando Moreno, Alvaro Rodriguez-Lescure, Diego Malon-Gimenez, Ana Isabel Ballesteros Garcia, Mercedes Marin-Aguilera, Patricia Galvan, Fara Braso-Maristany, Adrienne G. G. Waks, Sara M. M. Tolaney, Elizabeth A. A. Mittendorf, Ana Vivancos, Patricia Villagrasa, Joel. S. Parker, Charles M. M. Perou, Laia Pare, Guillermo Villacampa, Aleix Prat, Miguel Martin

Summary: This study evaluated the use of the HER2DX genomic assay in patients with ERBB2-positive breast cancer and found that it can predict the response to neoadjuvant trastuzumab-based chemotherapy with or without pertuzumab. This assay could be used to guide therapeutic decisions.

JAMA ONCOLOGY (2023)

Add to Collection

Article Cell Biology

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Carlo Genova, Roberta Tasso, Alessandra Rosa, Giovanni Rossi, Daniele Reverberi, Vincenzo Fontana, Silvia Marconi, Michela Croce, Maria Giovanna Dal Bello, Chiara Dellepiane, Marco Tagliamento, Maria Chiara Ciferri, Lodovica Zullo, Alessandro Fedeli, Angela Alama, Katia Cortese, Chiara Gentili, Eugenia Cella, Giorgia Anselmi, Marco Mora, Giulia Barletta, Erika Rijavec, Francesco Grossi, Paolo Pronzato, Simona Coco

Summary: The advent of immune checkpoint inhibitors (ICIs) has dramatically changed the treatment of non-small cell lung cancer (NSCLC). However, their efficacy remains limited to a subset of patients. This study evaluated the prognostic role of soluble (s) immune checkpoints and immune checkpoints associated with extracellular vesicles (EVs) in NSCLC patients treated with ICIs. The results showed that high levels of sPD-L1, sB7-H3, and sB7-H4 were associated with different prognoses in advanced NSCLC patients treated with ICIs. The study also suggested potential involvement of EVs in the disease response to ICIs.

CELLS (2023)

Add to Collection

Editorial Material Oncology

Does perioperative immunotherapy reduce the risk of second primary cancers?

Marco Tagliamento, Jordi Remon, David Planchard, Benjamin Besse

EUROPEAN JOURNAL OF CANCER (2023)

Add to Collection

Article Oncology

Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer

Maria Vittoria Dieci, Pierfranco Conte, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Daniele Generali, Federico Piacentini, Gaia Griguolo, Enrico Tagliafico, Fara Braso Maristany, Nuria Chic, Laia Pare, Federica Miglietta, Roberto Vicini, Roberto D'Amico, Sara Balduzzi, Aleix Prat, Valentina Guarneri

Summary: The integration of intrinsic molecular subtypes with stage or HER2DX risk score can predict site-specific metastatic risk in HER2-positive breast cancer, potentially impacting personalized surveillance and preventing site-specific recurrence in clinical trials.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.